Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rubella virus and arthritis.

C A Smith1, R E Petty, A J Tingle

  • 1Montefiore Medical Center Bronx, New York.

Rheumatic Diseases Clinics of North America
|August 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A perspective on vaccine evaluation research in Canada: Past and future.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.

Human immunology·2005
Same author

TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction.

Diabetologia·2002
Same author

Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type I diabetes mellitus.

Diabetologia·2000
Same author

Rubella virus vaccine associated arthropathy in postpartum immunized women: influence of preimmunization serologic status on development of joint manifestations.

The Journal of rheumatology·2000
Same author

CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility.

Human immunology·1999

Rubella virus and its vaccine commonly cause acute joint pain and arthritis. Rarely, these can lead to chronic or relapsing joint conditions, with this article exploring the mechanisms.

Area of Science:

  • Virology
  • Immunology
  • Rheumatology

Background:

  • Rubella virus and its vaccine are known triggers for acute arthralgia and arthritis.
  • Joint complications can manifest as acute, chronic, or relapsing conditions.

Purpose of the Study:

  • To detail the clinical illness associated with rubella virus.
  • To emphasize the arthritis syndromes resulting from rubella virus or vaccine exposure.
  • To explore potential pathogenetic mechanisms underlying rubella-induced joint manifestations.

Main Methods:

  • Literature review of rubella virus and associated arthritis.
  • Clinical case analysis of rubella-induced joint syndromes.
  • Pathophysiological examination of immune responses to rubella.

Related Experiment Videos

Main Results:

  • Rubella virus and vaccine frequently induce acute arthralgias and arthritis.
  • A subset of individuals may develop chronic or relapsing joint issues post-exposure.
  • The article provides an in-depth look at these joint manifestations and their potential causes.

Conclusions:

  • Rubella virus and vaccine are significant causes of acute arthritis.
  • Understanding the pathogenesis of rubella-associated arthritis is crucial for managing chronic or relapsing cases.
  • Further research into pathogenetic mechanisms may reveal novel therapeutic targets.